Renal Dysfunction in Patients with Left Ventricular Assist Device
References
- Virani SS, Alonso A, Benjamin EJ, et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics - 2020 Update: A Report From the American Heart Association. Circulation. 2020 Mar 3;141(9):e139-e596. doi: 10.1161/CIR.0000000000000757
- Modi K, Pannu AK, Modi RJ, et al. Utilization of Left Ventricular Assist Device for Congestive Heart Failure: Inputs on Demographic and Hospital Characterization From Nationwide Inpatient Sample. Cureus. 2021 Jul 1;13(7):
e16094 . doi: 10.7759/cureus.16094 - Raina R, Nair N, Chakraborty R, et al. An Update on the Pathophysiology and Treatment of Cardiorenal Syndrome. Cardiol Res. 2020;11(2):76-88. doi: 10.14740/cr955
- Verma D, Firoz A, Garlapati S, et al. Emerging Treatments of Cardiorenal Syndrome: An Update on Pathophysiology and Management. Cureus. 2021 Aug 17;13(8):
e17240 . doi: 10.7759/cureus.17240 - Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med. 1999 Aug 19;341(8):577-85. doi: 10.1056/NEJM199908193410806
- Rangaswami J, Bhalla V, Blair JEA, et al; on behalf of the American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2019;139:e840–e878. doi: 10.1161/CIR.0000000000000664
- Ronco C, Bellasi A, Di Lullo L. Cardiorenal Syndrome: An Overview. Adv Chronic Kidney Dis. 2018;25(5):382-390. doi: 10.1053/j.ackd.2018.08.004
- Hanberg JS, Sury K, Wilson FP, et al. Reduced Cardiac Index Is Not the Dominant Driver of Renal Dysfunction in Heart Failure. J Am Coll Cardiol. 2016 May 17;67(19):2199-2208. doi: 10.1016/j.jacc.2016.02.058
- Dupont M, Mullens W, Finucan M, et al. Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment. Eur J Heart Fail. 2013 Apr;15(4):433-40. doi: 10.1093/eurjhf/hfs209
- Nohria A, Hasselblad V, Stebbins A, et al. Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol. 2008 Apr 1;51(13):1268-74. doi: 10.1016/j.jacc.2007.08.072
- Cooper WA, O’Brien SM, Thourani VH, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation. 2006;113(8):1063-1070. doi: 10.1161/CIRCULATIONAHA.105.580084
- O’Neal JB, Shaw AD, Billing FT. Acute kidney injury following cardiac surgery: current understanding and future directions. Crit Care. 2016 Jul 4;20(1):187. doi: 10.1186/s13054-016-1352-z
- Kamboj M, Kazory A. Left Ventricular Assist Device and the Kidney: Getting to the Heart of the Matter. Blood Purif. 2019;48(4):289-298. doi: 10.1159/000502080.
- Ibrahim M, Saint Croix GR, Lacy S, Chaparro S. Impact of Renal Dysfunction on Outcomes after Left Ventricular Assist Device: A Systematic Review. Int J Heart Fail. 2021 Jan;3(1):69-77. doi: 10.36628/ijhf.2020.0030
- Kirklin JK, Naftel DC, Pagani FD, et al. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant. 2015 Dec;34(12):1495–504. doi: 10.1016/j.healun.2015.10.003
- Aaronson KD, Slaughter MS, Miller LW, et al. HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial Investigators. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012 Jun 26;125(25):3191-200. doi: 10.1161/CIRCULATIONAHA.111.058412
- Slaughter MS, Pagani FD, McGee EC, et al. HeartWare Bridge to Transplant ADVANCE Trial Investigators. HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial. J Heart Lung Transplant. 2013 Jul;32(7):675-83. doi: 10.1016/j.healun.2013.04.004
- Asleh R, Schettle S, Briasoulis A, et al. Predictors and Outcomes of Renal Replacement Therapy After Left Ventricular Assist Device Implantation. Mayo Clin Proc. 2019 Jun;94(6):1003-1014. doi: 10.1016/j.mayocp.2018.09.021
- Jawaid O, Gaddy A, Omar HR, Guglin M. Ventricular Assist Devices and Chronic Kidney Replacement Therapy: Technology and Outcomes. Adv Chronic Kidney Dis. 2021 Jan;28(1):37-46. doi: 10.1053/j.ackd.2021.01.002
- Kilic A, Chen CW, Gaffey AC, et al. Preoperative renal dysfunction does not affect outcomes of left ventricular assist device implantation. J Thorac Cardiovasc Surg. 2018;156(3):1093-1101.e1. doi: 10.1016/j.jtcvs.2017.12.044
- Brisco MA, Kimmel SE, Coca SG, et al. Prevalence and prognostic importance of changes in renal function after mechanical circulatory support. Circ Heart Fail. 2014 Jan;7(1):68–75. doi: 10.1161/CIRCHEARTFAILURE.113.000507
- Raichlin E, Baibhav B, Lowes BD, et al. Outcomes in Patients with Severe Preexisting Renal Dysfunction After Continuous-Flow Left Ventricular Assist Device Implantation. ASAIO J. 2016 May-Jun;62(3):261–7. doi: 10.1097/MAT.0000000000000330
- Gambaro A, Lombardi G, Onorati F, et al. Heart, kidney and left ventricular assist device: a complex trio. Eur J Clin Invest. 2021;51(12):
e13662 . doi: 10.1111/eci.13662 - Cornwell WK
3rd , Tarumi T, Stickford A, et al. Restoration of Pulsatile Flow Reduces Sympathetic Nerve Activity Among Individuals With Continuous-Flow Left Ventricular Assist Devices. Circulation. 2015;132(24):2316-2322. doi: 10.1161/CIRCULATIONAHA.115.017647 - Ootaki C, Yamashita M, Ootaki Y, et al. Reduced pulsatility induces periarteritis in kidney: role of the local renin-angiotensin system. J Thorac Cardiovasc Surg. 2008;136(1):150-158. doi: 10.1016/j.jtcvs.2007.12.023
- de Nattes T, Litzler PY, Gay A, et al. Hemolysis induced by Left Ventricular Assist Device is associated with proximal tubulopathy. PLoS One. 2020;15(11):
e0242931 . doi: 10.1371/journal.pone.0242931 - Roehm B, Grodin JL. Left Ventricular Assist Device Implantation and Kidney Function: Chicken, Egg, or Omelet? Kidney Med. 2021 May 8;3(3):324-326. doi: 10.1016/j.xkme.2021.04.003
- Pinsino A, Mondellini GM, Royzman EA, et al. Cystatin C- Versus Creatinine-Based Assessment of Renal Function and Prediction of Early Outcomes Among Patients With a Left Ventricular Assist Device. Circ Heart Fail. 2020 Jan;13(1):
e006326 . doi: 10.1161/CIRCHEARTFAILURE.119.006326 - Ivey-Miranda JB, Inker LA, Griffin M, et al. Cystatin C and Muscle Mass in Patients With Heart Failure. J Card Fail. 2021 Jan;27(1):48-56. doi: 10.1016/j.cardfail.2020.07.013
- Dalia T, Chan WC, Sauer AJ, et al. Outcomes in Patients With Chronic Kidney Disease and End-stage Renal Disease and Durable Left Ventricular Assist Device: Insights From the United States Renal Data System Database. J Card Fail. 2022 Apr 22:S1071-9164(22)00488-2. doi: 10.1016/j.cardfail.2022.03.355
- Bansal N, Hailpern SM, Katz R, et al. Outcomes Associated With Left Ventricular Assist Devices Among Recipients With and Without End-stage Renal Disease. JAMA Intern Med. 2018;178(2):204-209. doi: 10.1001/jamainternmed.2017.4831
- Patel AM, Adeseun GA, Ahmed I, et al. Renal failure in patients with left ventricular assist devices. Clin J Am Soc Nephrol. 2013 Mar;8(3):484-96. doi: 10.2215/CJN.06210612
DOI: https://doi.org/10.14797/mdcvj.1146 | Journal eISSN: 1947-6108
Language: English
Page range: 19 - 26
Submitted on: Jun 8, 2022
Accepted on: Jul 14, 2022
Published on: Sep 6, 2022
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2022 Lamees I. El Nihum, Nina Manian, Priya Arunachalam, Qasim Al Abri, Ashrith Guha, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.